2BB score and signals
Tango Therapeutics, Inc.’s current 2BB score is 40 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 64 | High |
| Momentum | 52 | Stable |
| Financial strength | 45 | Normal |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2017 |
| Employees | 137 |
| 52-week range | $6.25 – $34.39 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.3523 | — | $0.00 |
| 2026-08-12 | — | -0.3248 | — | $0.00 |
| 2026-05-13 | -0.32 | -0.3196 | $0.00 | $0.00 |
| 2026-03-05 | -0.29 | -0.3264 | $0.00 | $510,408.00 |
Related companies
2BBBullish & Bearish